Atherosclerosis
Volume 205, Issue 1 , Pages 192-196 , July 2009

No association of two functional polymorphisms in human ALOX15 with myocardial infarction

  • Martin Hersberger

      Affiliations

    • Division of Clinical Chemistry and Biochemistry, University Children's Hospital Zurich and Center for Integrative Human Physiology, University of Zurich, Steinwiesstrasse 75, CH-8032 Zürich, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 44 266 7541; fax: +41 44 266 7169.
    • ,
  • Martina Müller

      Affiliations

    • Institute of Epidemiology, Helmholtz Zentrum München, Munich, Ingolstaedter Landstr. 1, 85764 Neuherberg, Germany
    • Ludwig-Maximilians-Universität München, Munich, Germany
    • ,
  • Jacqueline Marti-Jaun

      Affiliations

    • Division of Clinical Chemistry and Biochemistry, University Children's Hospital Zurich and Center for Integrative Human Physiology, University of Zurich, Steinwiesstrasse 75, CH-8032 Zürich, Switzerland
    • ,
  • Iris M. Heid

      Affiliations

    • Institute of Epidemiology, Helmholtz Zentrum München, Munich, Ingolstaedter Landstr. 1, 85764 Neuherberg, Germany
    • Ludwig-Maximilians-Universität München, Munich, Germany
    • ,
  • Stefan Coassin

      Affiliations

    • Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria
    • ,
  • Thomas F. Young

      Affiliations

    • Division of Clinical Chemistry and Biochemistry, University Children's Hospital Zurich and Center for Integrative Human Physiology, University of Zurich, Steinwiesstrasse 75, CH-8032 Zürich, Switzerland
    • ,
  • Vanessa Waechter

      Affiliations

    • Division of Clinical Chemistry and Biochemistry, University Children's Hospital Zurich and Center for Integrative Human Physiology, University of Zurich, Steinwiesstrasse 75, CH-8032 Zürich, Switzerland
    • ,
  • Christian Hengstenberg

      Affiliations

    • Klinik und Poliklinik für Innere Medizin II, Universität Regensburg, Regensburg, Germany
    • ,
  • Christine Meisinger

      Affiliations

    • Institute of Epidemiology, Helmholtz Zentrum München, Munich, Ingolstaedter Landstr. 1, 85764 Neuherberg, Germany
    • ,
  • Annette Peters

      Affiliations

    • Institute of Epidemiology, Helmholtz Zentrum München, Munich, Ingolstaedter Landstr. 1, 85764 Neuherberg, Germany
    • ,
  • Wolfgang König

      Affiliations

    • Department of Internal Medicine II-Cardiology, University of Ulm Medical Center, Ulm, Germany
    • ,
  • Stephan Holmer

      Affiliations

    • Department of Internal Medicine, Landshut Hospital, Landshut, Germany
    • ,
  • Heribert Schunkert

      Affiliations

    • Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Germany
    • ,
  • Norman Klopp

      Affiliations

    • Institute of Epidemiology, Helmholtz Zentrum München, Munich, Ingolstaedter Landstr. 1, 85764 Neuherberg, Germany
    • Ludwig-Maximilians-Universität München, Munich, Germany
    • ,
  • Florian Kronenberg

      Affiliations

    • Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria
    • ,
  • Thomas Illig

      Affiliations

    • Institute of Epidemiology, Helmholtz Zentrum München, Munich, Ingolstaedter Landstr. 1, 85764 Neuherberg, Germany

Received 4 July 2008 ,Revised 12 November 2008 ,Accepted 13 November 2008.

References 

  1. Wittwer J, Hersberger M. The two faces of the 15-lipoxygenase in atherosclerosis. Prostag Leukotr Ess Fatty Acids. 2007;77:67–77
  2. Belkner J, Wiesner R, Rathman J, et al. Oxygenation of lipoproteins by mammalian lipoxygenases. Eur J Biochem. 1993;213:251–261
  3. Cathcart MK, McNally AK, Chisolm GM. Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex. J Lipid Res. 1991;32:63–70
  4. Rankin SM, Parthasarathy S, Steinberg D. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J Lipid Res. 1991;32:449–456
  5. Sigari F, Lee C, Witztum JL, Reaven PD. Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL. Arterioscler Thromb Vasc Biol. 1997;17:3639–3645
  6. Sakashita T, Takahashi Y, Kinoshita T, Yoshimoto T. Essential involvement of 12-lipoxygenase in regiospecific andstereospecific oxidation of low density lipoprotein by macrophages. Eur J Biochem. 1999;265:825–831
  7. Serhan CN, Hamberg M, Samuelsson B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci USA. 1984;81:5335–5339
  8. Kuhn H, Belkner J, Zaiss S, Fahrenklemper T, Wohlfeil S. Involvement of 15-lipoxygenase in early stages of atherogenesis. J Exp Med. 1994;179:1903–1911
  9. Kuhn H, Heydeck D, Hugou I, Gniwotta C. In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J Clin Invest. 1997;99:888–893
  10. Ariel A, Li PL, Wang W, et al. The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering. J Biol Chem. 2005;280:43079–43086
  11. Shen J, Herderick E, Cornhill JF, et al. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest. 1996;98:2201–2208
  12. Shen J, Kuhn H, Petho-Schramm A, Chan L. Transgenic rabbits with the integrated human 15-lipoxygenase gene driven by a lysozyme promoter: macrophage-specific expression and variable positional specificity of the transgenic enzyme. FASEB J. 1995;9:1623–1631
  13. Cyrus T, Witztum JL, Rader DJ, et al. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest. 1999;103:1597–1604
  14. Huo Y, Zhao L, Hyman MC, et al. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2004;110:2024–2031
  15. Merched AJ, Ko K, Gotlinger KH, Serhan CN, Chan L. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J. 2008;
  16. Wittwer J, Marti-Jaun J, Hersberger M. Functional polymorphism in ALOX15 results in increased allele-specific transcription in macrophages through binding of the transcription factor SPI1. Hum Mutat. 2006;27:78–87
  17. Wittwer J, Bayer M, Mosandl A, Muntwyler J, Hersberger M. The c.−292C>T promoter polymorphism increases reticulocyte-type 15-lipoxygenase-1 activity and could be atheroprotective. Clin Chem Lab Med. 2007;45:487–492
  18. Assimes TL, Knowles JW, Priest JR, et al. A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease. Atherosclerosis. 2008;198:136–144
  19. Lowel H, Doring A, Schneider A, et al. The MONICA Augsburg surveys—basis for prospective cohort studies. Gesundheitswesen. 2005;67(Suppl. 1):S13–18
  20. Herder C, Illig T, Baumert J, et al. RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. Eur J Endocrinol. 2008;158:R1–5
  21. Boes E, Kollerits B, Heid IM, et al. INSIG2 polymorphism is neither associated with BMI nor with phenotypes of lipoprotein metabolism. Obesity. 2008;16:827–833
  22. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002;70:425–434
  23. Hiltunen T, Luoma J, Nikkari T, Yla-Herttuala S. Induction of 15-lipoxygenase mRNA and protein in early atherosclerotic lesions. Circulation. 1995;92:3297–3303
  24. McCaskie P, Beilby J, Hung J, et al. 15-Lipoxygenase gene variants are associated with carotid plaque but not carotid intima–media thickness. Hum Genet. 2008;123:445–453
  25. Aggarwal NT, Chawengsub Y, Gauthier KM, et al. Endothelial 15-lipoxygenase-1 overexpression increases acetylcholine-induced hypotension and vasorelaxation in rabbits. Hypertension. 2008;51:246–251
  26. Aggarwal NT, Gauthier KM, Campbell WB. 15-Lipoxygenase metabolites contribute to age-related reduction in acetylcholine-induced hypotension in rabbits. Am J Physiol. 2008;295:H89–96
  27. Chawengsub Y, Aggarwal NT, Nithipatikom K, et al. Identification of 15-hydroxy-11,12-epoxyeicosatrienoic acid as a vasoactive 15-lipoxygenase metabolite in rabbit aorta. Am J Physiol. 2008;294:H1348–1356
  28. Muntwyler J, Marti-Jaun J, Luscher TF, Hanseler E, Hersberger M. No evidence for involvement of the human inducible nitric oxide synthase gene in susceptibility to coronary artery disease. Clin Chem Lab Med. 2005;43:253–255
  29. Hersberger M, Muntwyler J, Funke H, et al. The CAG repeat polymorphism in the androgen receptor gene is associated with HDL-cholesterol but not with coronary atherosclerosis or myocardial infarction. Clin Chem. 2005;

PII: S0021-9150(08)00810-1

doi: 10.1016/j.atherosclerosis.2008.11.017

Atherosclerosis
Volume 205, Issue 1 , Pages 192-196 , July 2009

Article Tools